The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis.
<h4>Background</h4>The prognostic value of p16 promoter hypermethylation in cancers has been evaluated for several years while the results remain controversial. We thus performed a systematic review and meta-analysis of studies assessing the impact of p16 methylation on overall survival...
Saved in:
| Main Authors: | Xiang-Bin Xing, Wei-Bin Cai, Liang Luo, Long-Shan Liu, Hui-Juan Shi, Min-Hu Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0066587&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients
by: Gayatri Sharma, et al.
Published: (2009-01-01) -
The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
by: Zhang Lou-Qian, et al.
Published: (2013-01-01) -
Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
by: Oscar Gee-Wan Wong, et al.
Published: (2010-01-01) -
The prognostic value of p16ink4a marker in the diagnosis of cervical dysplasia
by: E. A. Dyadyk, et al.
Published: (2012-08-01) -
Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma
by: Benjamin Stubbe, et al.
Published: (2025-05-01)